NCT00496730
A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)
See it on ClinicalTrials.gov ↗256 people
30.9%
69.1%
79 womenmiddle line = equal numbers177 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2008-08
- Health conditions
- Hypercholesterolemia
- Who could join
- Anyone
- Ages
- 20 Years – 79 Years
- Average age
- mean 59.61 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 26.61 kg/m^2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Myocardial Infarction, coronary artery bypass surgery, or angioplasty within 3 months”
Study titles and rules are shown in their original English.